Literature DB >> 10673225

Pharmacological characterization of leukotriene receptors.

S E Dahlén1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10673225     DOI: 10.1164/ajrccm.161.supplement_1.ltta-9

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

Review 1.  Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

Authors:  Richard B R Muijsers; Stuart Noble
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation.

Authors:  Xiaoju Tang; Xiaojing J Liu; Cuijie Tian; Qiaoli Su; Yi Lei; Qingbo Wu; Yangyan He; Jeffrey A Whitsett; Fengming Luo
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

4.  An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.

Authors:  M Bäck; M Kumlin; I A Cotgreave; S E Dahlén
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 5.  Pranlukast: a review of its use in the management of asthma.

Authors:  Susan J Keam; Katherine A Lyseng-Williamson; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Targeting cell signaling in allergic asthma.

Authors:  Seyyed Shamsadin Athari
Journal:  Signal Transduct Target Ther       Date:  2019-10-18

Review 7.  Integrating evidence for managing asthma in patients who smoke.

Authors:  David Price; Leif Bjermer; Todor A Popov; Alison Chisholm
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-17       Impact factor: 5.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.